ARCHIVES

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

This article is from The Cancer Letter archive.

Vol. 23 No. 30 | August 1, 1997

Download PDF Visit The Full Archive

Related Articles

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

July 3, 2013

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014